Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) was the recipient of a significant decline in short interest in February. As of February 28th, there was short interest totalling 15,700 shares, a decline of 29.0% from the February 13th total of 22,100 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ? days.
Basilea Pharmaceutica Price Performance
Shares of BPMUF opened at $52.83 on Monday. The company has a current ratio of 4.10, a quick ratio of 3.27 and a debt-to-equity ratio of 5.70. Basilea Pharmaceutica has a one year low of $38.60 and a one year high of $52.83. The stock has a 50 day moving average price of $52.83 and a 200 day moving average price of $52.49.
Basilea Pharmaceutica Company Profile
Read More
- Five stocks we like better than Basilea Pharmaceutica
- Market Cap Calculator: How to Calculate Market Cap
- How to Build the Ultimate Everything ETF Portfolio
- Investing in Travel Stocks Benefits
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- The 3 Best Retail Stocks to Shop for in August
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.